Switch to:
More From Other Websites
Inversion Deals Aren’t Dead, They’re Just More Low-Key: Real M&A Apr 24 2015
Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog Apr 24 2015
Why Are Shire PLC And Hikma Pharmaceuticals Plc Wiping The Floor With GlaxoSmithKline plc? Apr 24 2015
Shire Gets Dropped from AQR Capital’s Portfolio Apr 23 2015
AbbVie raises outlook as Humira again delivers earnings beat Apr 23 2015
AbbVie raises outlook as Humira again delivers earnings beat Apr 23 2015
Roche Beats on Q1 Sales driven by Oncology & Immunology - Analyst Blog Apr 23 2015
AbbVie raises guidance after 1Q sales beat Apr 23 2015
AbbVie raises guidance after 1Q sales beat Apr 23 2015
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog Apr 22 2015
Hedge fund manager targets patent for Biogen's blockbuster MS drug, Tecfidera Apr 22 2015
3 Large-Cap Pharmaceutical Companies to Invest in Right Now Apr 22 2015
Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog Apr 21 2015
Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog Apr 21 2015
Ampio Plunges as STRIDE Study on Ampion Fails - Analyst Blog Apr 21 2015
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Apr 21 2015
Shire to announce first quarter 2015 results Apr 21 2015
Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent Apr 20 2015
Should You Sell Petrofac Limited, Shire PLC And Standard Chartered PLC? Apr 20 2015
Goldman's Monster Q1 Spurred By Megadeals, Volatility Apr 16 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK